Frontiers | Cross-Reactive Immunity Among Flaviviruses
Cross-reactive anti-CCD antibodies can hinder allergy diagnostics - EUROIMMUNBlog
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology
Cross-reactivity of Antibody: Beneficial or Harmful? - Cusabio
T‐cell cross‐reactivity may explain the large variation in how cancer patients respond to checkpoint inhibitors - Sioud - 2018 - Scandinavian Journal of Immunology - Wiley Online Library
A cross-reactive antibody protects against Ross River virus musculoskeletal disease despite rapid neutralization escape in mice | PLOS Pathogens
Cross-reactive immunity against coronaviruses
Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses - ScienceDirect
Cross-reactivity of Antibody: Beneficial or Harmful? - Cusabio
Human antibody responses after dengue virus infection are highly cross- reactive to Zika virus | PNAS
Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination | Science
Frontiers | Virus-Induced T Cell-Mediated Heterologous Immunity and Vaccine Development
Introduction to Allergy and Diagnosis -Alliance Allergy
Vaccines | Free Full-Text | Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine
JCI - Seasonal coronavirus–specific B cells with limited SARS-CoV-2 cross- reactivity dominate the IgG response in severe COVID-19
Affinity, Avidity and Cross Reactivity (FL-Immuno/42) - YouTube
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination | eLife
Remembering seasonal coronaviruses | Science
Frontiers | Heterologous Immunity: Role in Natural and Vaccine-Induced Resistance to Infections
Molecular Mimicry: Cross-Reactivity Between Microbes and Host Proteins as a Cause of Autoimmunity | SpringerLink
Food Allergies and Cross-Reactivity
Manipulating the Selection Forces during Affinity Maturation to Generate Cross-Reactive HIV Antibodies: Cell
Antigen-antibody reactions
